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Abstract 





U) is a component of the ubiquitous background radiation dose
1
.  It is of interest to compare the 
concentration distribution of these natural α-emitters in the lungs and respiratory lymph nodes with 
those resulting from occupational exposure, including exposure to anthropogenic plutonium, depleted 
and enriched uranium.  This study examines the application of laser ablation-inductively coupled plasma-
mass spectrometry (LA-ICP-MS) to quantifying and visualizing the mass distribution of uranium and 
thorium isotopes from both occupational and natural background exposure in human respiratory tissues, 
and for the first time, extends this application to the direct imaging of plutonium isotopes.  Sections of 
lymphatic and lung tissues taken from deceased former nuclear workers with known history of 
occupational exposure to specific actinide elements (uranium, plutonium or americium) were analyzed by 
LA-ICP-MS.  Using a previously developed LA-ICP-MS protocol for elemental bio-imaging of trace elements 











Pu) mass distributions in sections of tissue.  We used a laboratory-produced 










Pu were detected by LA-ICP-MS in 65-µm-diameter localized regions of both a paratracheal 
lymph node and a sample of lung tissue from a person who was occupationally exposed to refractory 
plutonium (plutonium dioxide). The average (overall) 
239
Pu concentration in the lymph node was 39.2 
ng/g, measured by High Purity Germanium (HPGe) γ-spectrometry
2
.  Localized mass concentrations of 
thorium (
232
Th) and uranium (
238
U) in lymph node tissue from a person not occupationally exposed to 
these elements (chronic natural background inhalation exposure) ranged up to 400 and 375 ng/g, 




U concentrations ranged up to 200 and 170 ng/g, respectively. In a person occupationally exposed to 
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U isotopic mass concentrations in a lymph node, 
measured at higher resolution (with a 30-µm laser spot diameter), were 70 and 8500 ng/g, respectively.  
The ratio of these simultaneously measured mass concentrations signifies natural uranium.  The current 
technique was not sufficiently sensitive, even with a 65-µm laser spot diameter, to detect 
241
Am (at an 
overall tissue concentration of 0.024 ng/g, i.e., 3 Bq/g).  
 
Introduction 
Since its inception in 1968 as the National Plutonium Registry, the United States Transuranium and 
Uranium Registries (USTUR) has been quantifying individual exposures to actinide elements and following 
health outcomes in nuclear industry workers
4
.  The mission of the USTUR is to study occupationally 
exposed workers from the point of exposure to death.  The USTUR measures the uptake, translocation 
and retention (biokinetics) of plutonium, americium, uranium, and other actinides.  The USTUR is also a 
national and international resource for testing and improving the application of excreta monitoring and 
other contemporary bioassay data to predict tissue dose rates measured at autopsy.  Registered workers 
were mostly employed at weapons sites. They received substantial accidental intakes of plutonium, 
americium and/or uranium, since as far back as the Manhattan Project (1944-46). The USTUR and the 
associated National Human Tissue Repository (NHRTR) is a unique resource for preserved tissues and 
radiometric analysis data – linked to individual-specific health physics monitoring data, health records and 
pathology findings.  To date, USTUR is the custodian of tissue radioanalysis data (and preserved tissue 
samples) from 325 donors – including 36 whole-body donors.  
Elemental bio-imaging (EBI) is a potential application of laser ablation-inductively coupled plasma-mass 
spectrometry (LA-ICP-MS) for the determination of actinide distributions in human tissue samples.  
Briefly, a focused laser beam is directed onto the surface of a tissue sample, and the ablated material is 
transported to the ICP-MS by a carrier gas.  By traversing the laser beam across the sample, the resultant 
mass spectra can be combined into two-dimensional maps displaying the relative intensity of measured 
isotopes throughout the tissue section.  Quantitative data can be recorded by the ablation of matrix-
matched tissue standards and construction of multi-point calibration curves.  We have previously 
described the use of EBI in the elemental analysis of Parkinsonism animal models
5
, human osteoarthritic 
tissue
6
 and human melanoma samples
7
.  
Traditionally, the measurement of plutonium (
238,239+240
Pu) and americium (
241
Am) in biological samples 
has relied upon radiometric analysis.  Radiochemical methods for the analysis of human tissues, 
previously reported by both the USTUR and the Russian Dosimetry Registry of the Mayak Industrial 
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Association (DRMIA), require dry/wet ashing and dissolution in mineral acids followed by radiochemical 
separation and alpha-spectrometric detection of the actinides
8
.  A similar method was used to measure 
the plutonium content of tissues and bones from residents of Tokyo (Japan)
9
.   
For the past decade, ICP-MS has been established as a method for actinide bioassay, e.g., to measure the 
concentrations of uranium isotopes in urine for both environmental
10-12
 and occupational exposures
13
, as 
well as environmental thorium and uranium in blood
14
.  Recently, the application of ICP-MS for fast 
bioassay of plutonium in feces has also been described
15
. 
LA-ICP-MS has been applied to the imaging of uranium (
238
U) and thorium (
232
Th) in plant materials
16
, 
human brain tumour resections
17
, human hippocampus sections
18
, and in coronal rat brain sections
19
.  It 
was unclear if environmental exposure or another external source accounted for the presence of uranium 
and thorium in brain tissue. 










Pu in human lymph node and lung tissues.  The LA-ICP-MS method presented in this study 
did not require extensive or potentially biohazardous sample preparation (as is required for radiometric 
analysis), yet it does enable concentration measurements of actinides in human tissues to be made at low 




All experiments were carried out using a New Wave UP-213 laser ablation unit (Kenelec Technologies, 
Mitcham, Victoria, Australia).  The UP-213 emits a 213 nm laser pulse from a Nd:YAG solid state gain 
medium.  The laser unit was connected to an Agilent Technologies 7500ce ICP-MS (Forrest Hill, Victoria, 
Australia) with a ‘cs’ lens system for enhanced sensitivity.  The LA-ICP-MS system was tuned for maximum 
sensitivity prior to each experiment using NIST 612 Trace Elements in Glass.  NIST glass was also used to 




) ratio was consistently less than 0.3%.  Typical 
operational parameters are given in Table 1. 
The laser energy density was maintained at 0.3 J cm
-2
. This laser power minimized fracturing of the tissue 
due to vaporization of water. The laser frequency was 20 Hz.  Laser spot diameters were selected to 
ensure a good balance between image resolution and sample runtime, which was up to 24 hours, 
depending on the sample size. 
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Solution nebulisation (SN)-ICP-MS was performed for the analysis and quantification of the matrix-
matched tissue standards that were employed for quantification of the samples.  These experiments were 
performed on a separate Agilent 7500 ce ICP-MS fitted with an I-AS autosampler (Agilent, Australia).  A 
250 ppb solution of 
103
Rh was used as the reference element that was added to each sample via a 
peristaltic pump and T-piece connector.  A quartz concentric nebulizer and Scott-type spray chamber 
(Glass Expansion, Australia) were used.  Helium was used as a collision gas to remove polyatomic 
interferences.  Parameters are outlined in Table 1. 
Table 1: SN / LA-ICP-MS operational parameters.  
Agilent 7500ce ICP-MS New Wave UP213 Laser Ablation 
 LA SN Wavelength, nm 213  
Rf Power, W 1200  1500  Repetition frequency, Hz 20  
Cooling gas flow rate, L min
-1
 15.0  15.0 Laser energy density, J cm
-2
 0.3  
Carrier gas flow rate, L min
-1
 1.1   0.8  Spot size, µm 30, 65 
Sample depth, mm 6.0   8.0 Scan rate, µm s
-1
 30, 65  
QP Bias, V -5.0 -5.0  Line spacing, µm 30, 65  
OctP Bias, V -8.0 -8.0 Carrier gas Ar 
Scan mode Peak hopping Monitored at 30 µm, m/z 232, 235, 238 
Dwell time, s per m/z 0.1  0.1  Monitored at 65 µm, m/z 232,235,238, 239, 240, 241 
Extracts 1;2, V 6.8 ; -126  0; -125   
Collision gas None  He   
 
Human tissue sample preparation for EBI 
Samples frozen at -30°C (the standard protocol for long-term storage of NHRTR tissues) were de-frosted 
and fixed in 10% buffered formalin for preservation during shipment. Human tissue samples (2 samples of 
lung tissue and 3 lymph nodes) were received from USTUR (Table 2).   
Table 2.  USTUR tissue samples by case number and primary exposure element 
USTUR Sample #  Tissue description Weight (g) Primary exposure nuclide 
246.610 Lung (R) - Superior Lobe 3.22 Am 
303.007 LN Tracheobronchial (R) 0.92 Pu 
407.002 LN Paratracheal (R) 0.26 Pu 
407.630 Lung (R ): Inferior 1.36 Pu 
1060.304 LN Parabronchial (L) 0.12 U (natural) 
 
For LA-ICP-MS measurements, the shipment formalin was decanted and samples were frozen in iso-
pentane/liquid nitrogen and mounted in Tissue-Tek OCT freezing media (ProSciTech, Kirwan, Queensland, 
Australia).  Samples were then sectioned at 30 µm on a cryostat using C.L. Sturkey Diamond PTFE-coated 
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disposable microtome blades and mounted on high-purity StarFrost microscope slides (ProSciTech).  After 
sectioning, the remaining tissue samples were returned to the buffered formalin solution for 
preservation. Prepared sample sections were ablated at ambient temperature.    
 
Thorium and uranium quantification procedure 
The quantification method for thorium and uranium was adapted from Hare et al.
5
 as follows.  Chicken 
breast tissue was obtained from a local market and was stripped of all fatty and connective tissue using a 
PTFE-coated scalpel.  Approximately 5 g portions of the tissue were spiked with volumes of 100 mg/L
 
Th 
and U standards in 5 % HNO3 (Choice Analytical, Thornleigh, NSW, Australia) as listed in Table 3.  A further 
volume of 5 % Seastar Baseline grade HNO3 (Choice Analytical) was added to a final mass of 6 g to aid 
homogenization.  Homogenization was performed using an OmniTech TH tissue homogenizer fitted with 
polycarbonate probes (Kelly Scientific, North Sydney, NSW, Australia).  Six aliquots (ca. 100 mg) of 
accurately weighed homogenized tissue were then digested in 4:1 70 % Baseline HNO3
 
(Choice Analytical) 
and Ultrapure 31 % H2O2 (Merck, Kilsyth, Victoria, Australia) using a Milestone MLS 1200 closed vessel 
microwave digester.  The digests were gravimetrically diluted to ca. 50 g with 18.2 mΩ deionised H2O. 
These digests were quantified by solution nebulisation ICP-MS. Standards for quantification were 
prepared from fresh 1000 ppm stocks (Choice Analytical) to determine the total uranium and thorium 
content of the digests (including any U and Th endogenous to the sample prior to spiking). The %RSD for 
the 6 aliquots was calculated (< 5%) to ensure homogeneity.   These standards were then packed into 1 
cm
2
 histology moulds, frozen in liquid nitrogen/isopentane and sectioned on a cryostat. Calibration curves 
for LA-ICP-MS were constructed by ablating representative areas of each of the standards prior to the 
analysis of each sample.   
Table 3: Spiked volumes and final concentrations of matrix-matched tissue standards. 
 Approximate spiked volume of 100 mg/L standard solution (µL) Final concentration (ng/g) 
10 171.8 Th 
100 1537 
10 130.9 U 
100 1812 
 
Qualitative analysis of plutonium isotopes 
239,240
Pu isotopic standard solutions are not currently availability in Australia.  Therefore, the results are 
presented as the raw signal intensity values (cps) for m/z = 239, 240. 
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 Image construction 
A laser spot size of 65 µm and scan speed of 65 µm s
-1
 was used in all cases, except USTUR Case 1060 
(occupational exposure to uranium) for which a laser spot size of 30 µm and scan speed of 30 µm s
-1 
were 
also used to produce higher resolution images. The MS integration time was set in each experiment to 
ensure true image resolution was as close to 65 µm (or 30 µm) as possible.  Images were subsequently 
produced using in-house ISIDAS (Interactive Spectral Imaging Data Analysis Software) suite written in 
Python programming language to reduce all MS scan data into two-dimensional images.  These images 
were exported from ISIDAS as Visualization Toolkit (.vtk) files into the MayaVi2 (Enthought, Inc., Austin, 
Texas, USA) for final image rendition. 
 
Sample case descriptions 
USTUR Case 0407  
This gentleman was employed at the Rocky Flats Plutonium Fabrication Plant in Colorado, USA from 1958 
to 1975
20
.  In 1965 he was involved in an extensive plutonium fire incident.  Examination of the plutonium 
fire aerosol showed that the material was highly refractory (insoluble) and this was avidly retained in the 
lungs.  For this reason intravenous chelation therapy with calcium diethylenetriaminepentaacetic acetate 
(Ca-DPTA) was ineffective, and the Registrant was reassigned to non-plutonium work.  There is no record 
of this registrant having worked with uranium or thorium.  He passed away in 2008 at age 90+ years from 
heart failure.  This Registrant was a whole body donor and the lung and lymph node samples studied here 
were taken at autopsy. 
USTUR Case 0303 
Case 0303
21
 was employed for 30 years at the Hanford complex.  He was involved in several minor 
plutonium exposures and a major exposure in 1968, when he punctured his protective glove and cut his 
finger on Pu-contaminated equipment.  The wound was heavily contaminated with soluble plutonium.   
Tissue surrounding the wound was excised and intravenous administration of Ca-DPTA enhanced his 
urinary excretion of plutonium.  He did not work with uranium.  The Registrant died in 2008 at age 87.  A 
tracheobronchial lymph node (taken at autopsy) was studied here. 
USTUR Case 0246 
This Registrant was employed at the Hanford nuclear materials complex in Washington, USA for 25 
years
22
.  In 1976 an ion-exchange column containing approximately 100 g of 
241
Am that he was working on 
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exploded, causing him severe acid burns and cuts to his face and upper body.  Intravenous Ca-DPTA 
treatment was commenced promptly, followed by several years of intravenous Zn-DPTA chelation 
therapy.  The Registrant died in 1987 at 75 years of age, from emphysema.  Prior to his accidental 
241
Am 
exposure, he had suffered a myocardial infarction and coronary artery disease. A right lung superior lobe 
(taken at autopsy) was studied here. 
USTUR Case 1060 
This Registrant worked at the Hanford complex for 40 years, where he was chronically exposed to 
uranium from 1948 to 1950 whilst working in the uranium melt plant
23
. The form of the uranium was 
most likely U3O8. Urinalysis suggested there was a single acute incident of uranium exposure occurring in 
1948 in addition to chronic U dietary intake. This Registrant was also involved in several plutonium 
contamination incidents and was potentially exposed to elevated airborne plutonium concentrations on 
two occasions, but only one urine measurement exceeded the minimum detectable activity (MDA) for 
plutonium.  The Registrant died (in 2008) at age 83, of a cerebral infarct due to thrombosis of the left 
carotid artery.  A left parabronchial lymph node (taken at autopsy) was studied here.  
 
Results and discussion 
Plutonium exposure 
USTUR Case 0407 
Figure 1 shows a light micrograph and images of m/z 232, 238, 239 and 240 in the paratracheal lymph 










atom ratio (0.02 – 0.08) expected for weapons grade plutonium
24
.  From γ-spectrometric measurements, 
the average 
239
Pu concentration in the whole lymph node was estimated to be 39 ng/g.  
241
Am was not 




(0.2ng/g) estimated by γ-spectrometry was 
below the estimated 1 ng/g detection limit of the instrument. The signal at m/z = 239 was solely due to 
239




 isobaric ion, as a signal at 239 was not detected in other samples with high 
concentrations of 
238
U such as Case 1060 ( 8500 ng/g).  
Figure 1 clearly indicates inhomogeneous distribution of all measured actinides in the lymph node, with 




U (presumably from chronic natural background inhalation 




Pu (from occupational exposure).  The measured 
232
Th 
concentration ranged up to 300 ng/g. 
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An inhomogeneous actinide distribution was also found in the lung (Figure 2). This lung segment from the 
inferior right lobe shows two distinctive areas of signal at m/z = 239, with no corresponding signal 
recorded for m/z = 240.  Figure 3 shows that the location of the m/z=239 signal (
239
Pu) from acute 
accidental inhalation was correlated with that of m/z = 232 (
232
Th) from chronic background inhalation.   
 
 
Figure 1: Photomicrograph (top) and m/z 232, 238, 239 and 240 images (65-µm scan spot) of paratracheal 
lymph node from USTUR Case 0407. 
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 Figure 2: Photomicrograph (top) and 232, 238 and 239 images (65-µm scan spot) from inferior right lung 
segment (approx. 3 cm long) from USTUR Case 0407. 
 
 
Figure 3: Corresponding m/z 232 and 239 particles in inferior right lung tissue in USTUR Case 0407. 
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 USTUR Case 0303 
This Registrant had suffered a skin puncture wound contaminated with a soluble form of plutonium.  This 
incident may also have released some airborne plutonium.  The right tracheobronchial lymph node 
showed no detectable quantities of Pu-material at m/z 239 or 240.  This confirmed the soluble nature of 
any inhaled plutonium.   




U in the lymph node ranging up to 400 and 375 ng/g, 
respectively. Lateral image resolution was 65 µm.  The Registrant did not work with these nuclides, and so 





U maximum concentrations are close to the values measured in the lymph node from Case 0407 of 
(300 ng/g and 200 ng/g, respectively), who also did not work with these radionuclides.  It was extremely 
unlikely that the measured 
232
Th concentrations in the lymph node arose from adventitious exposure at 
the Rocky Flats and Hanford sites since this material was not involved in their production processes.  The 
measured 
238
U concentrations are similar to those of 
232
Th, and are thus also most likely to have arisen 
from chronic (natural) background inhalation of uranium.  
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 Figure 4: Photomicrograph (top) and m/z 232 and 238 images (65-µm scan spot) of right tracheobronchial 
lymph node from USTUR Case 0303.  
 
Americium exposure 
USTUR Case 0246 
241
Am was not detected in the section of right superior lung lobe analyzed here. This null observation is 
consistent with previous radiochemical 
241
Am analyses (3 Bq/g or 0.024 ng/g) in the right lung
25
.  This 
concentration is well below the limit of detection of the currently used LA-ICP-MS system.  However, as 




U, presumably from chronic natural 
background inhalation were observed, with concentrations ranging up to 200 ng/g and 100 ng/g, 
respectively (Figure 5).  
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U images (65-µm scan spot) from superior right lung 
tissue from USTUR Case 0246. 
Uranium and thorium exposure 
USTUR Case 1060 
The parabronchial lymph node from Case 1060 (Figure 6) showed ~20 – 40 times higher 
238
U 
concentration than the lymph nodes from Cases 0303 and 0407.  Furthermore, 
235
U was detected in the 
Case 1060 lymph node.  The high measured values of 
238
U and delectability of 
235
U, and low 
232
Th are 
consistent with this Registrant’s known occupational exposure to uranium but not to thorium. 






U concentrations measured for Case 1060 with those 
measured for the other three USTUR cases. 
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U tissue concentrations from natural background and 
occupational uranium exposures in former nuclear workers 
Maximum isotopic concentration, ng/g USTUR 










1060.304 LN Parabronchial (L) occupational
†
 160 70 8500 
0246.610 Lung (R) - Superior Lobe chronic natural 200  N.D.
‡
 100 
0303.007 LN Tracheobronchial (R) chronic natural 400  N.D. 375 
0407.002 LN Paratracheal (R) chronic natural 300  N.D. 200 
0407.630 Lung (R ): Inferior chronic natural 40  N.D. 170 
†- chronic exposure to natural 232Th, ‡ - not detected  
 
As shown in Table 4, the maximum concentration of 
232
Th in lung from (presumed) natural background 
inhalation exposure ranged within 40 – 200 ng/g and within 160 – 400 ng/g in lymph node samples. No 
235
U was detected in either lymph node or lung samples from cases with these low background exposures 
and the 
238
U concentration in lungs (100 – 170 ng/g) was about half that in lymph nodes (200 – 375 ng/g).  
USTUR Registrant 1060 was chronically exposed to uranium of natural composition at work
3
 for several 




Figure 6: Photomicrograph (top) and m/z 232, 235 and 238 images (30-µm scan spot) of left parabronchial 
lymph node from USTUR Case 1060. 
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Pu was detected in the lymph node. This null observation is consistent with the health physics 
monitoring data in this case, which recorded only one positive measurement of Pu in urine
23
.  However, 
non-detection of any signal at m/z = 239 in this high uranium exposure case (at 8500 ng/g 
238
U) is 









Elemental bio-imaging by LA-ICP-MS is a useful tool for both visualization and quantitative determination 
of the localized mass concentrations of the actinide elements Th and U in human tissues, for both chronic 




Pu is demonstrated for lymph node and lung samples from an occupationally exposed person. The 
distributions of thorium, uranium and plutonium isotopes in all sections of lymph node and lung analyzed 
were highly inhomogeneous, indicating localized aggregation of the inhaled particles for both chronic 
natural background and acute occupational actinide exposures.  This work provides a significant new 
capability to study the micro-distribution of long-lived actinides in human tissues, and thus directly 
address issues of non-uniformity of radiation dose.  Furthermore, we are extending the method to the 
field of industrial hygiene for former nuclear workers, in particular to the localization and quantification of 
beryllium, and potentially asbestos, in lung and lymph nodes.  
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